Remarkably, the combination of salubrinal and AAV8‐based RS1 delivery significantly reduced both CHOP levels and the number of apoptotic cells, demonstrating a synergistic effect in mitigating retinoschisis and improving impaired ERG responses (Figure 8). This evidence concerns the gene DDIT3 and retinoschisis.